Trial Profile
A Phase III Randomized Trial of Comparison of Survival Benefit of Administration of Keytruda Via Hepatic Arterial Infusion Versus Vein for Immunotherapy of Advanced Liver Cancer
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary) ; Pembrolizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Dec 2018 New trial record